USA – Abbott has received FDA approval for its latest 3D cardiac mapping platform, which is intended to help physicians target abnormal heart rhythms. The EnSite X EP system inserts…
Read MoreUSA – Abbott has received FDA approval for its latest 3D cardiac mapping platform, which is intended to help physicians target abnormal heart rhythms. The EnSite X EP system inserts…
Read More